375 related articles for article (PubMed ID: 9867153)
21. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin?
Mann A; Ahlberg AW; White MP; Cross DM; Piriz J; Morris RS; Heller GV
J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
23. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease.
Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T
J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study.
Kao CH; ChangLai SP; Shen YY; Lee JK; Wang SJ
J Nucl Med; 1997 Jul; 38(7):1015-9. PubMed ID: 9225781
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
[TBL] [Abstract][Full Text] [Related]
26. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
31. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K
Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287
[TBL] [Abstract][Full Text] [Related]
33. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
35. Predicting the response to cardiac resynchronization therapy using 99mTc-tetrofosmin myocardial scintigraphy in patients with drug-refractory heart failure: additional value of the washout of 99mTc-tetrofosmin.
Shigeru M; Fujiwara S; Takamine S; Yoshida A; Kawai H; Shiotani H; Hirata K
Nucl Med Commun; 2014 Sep; 35(9):939-46. PubMed ID: 24977350
[TBL] [Abstract][Full Text] [Related]
36. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Söderlund V; Jonsson C; Bauer HC; Brosjö O; Jacobsson H
J Nucl Med; 1997 May; 38(5):682-6. PubMed ID: 9170427
[TBL] [Abstract][Full Text] [Related]
37. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
Higley B; Smith FW; Smith T; Gemmell HG; Das Gupta P; Gvozdanovic DV; Graham D; Hinge D; Davidson J; Lahiri A
J Nucl Med; 1993 Jan; 34(1):30-8. PubMed ID: 8418268
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
